BE866150A - Procede pour la preparation d'une souche virale de gastro-enterite transmissible attenuee a appliquer aux vaccins vivants - Google Patents

Procede pour la preparation d'une souche virale de gastro-enterite transmissible attenuee a appliquer aux vaccins vivants

Info

Publication number
BE866150A
BE866150A BE186927A BE186927A BE866150A BE 866150 A BE866150 A BE 866150A BE 186927 A BE186927 A BE 186927A BE 186927 A BE186927 A BE 186927A BE 866150 A BE866150 A BE 866150A
Authority
BE
Belgium
Prior art keywords
enteritis
mitigated
preparation
live vaccines
viral strain
Prior art date
Application number
BE186927A
Other languages
English (en)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of BE866150A publication Critical patent/BE866150A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/815—Viral vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BE186927A 1977-04-21 1978-04-19 Procede pour la preparation d'une souche virale de gastro-enterite transmissible attenuee a appliquer aux vaccins vivants BE866150A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7704348A NL7704348A (nl) 1977-04-21 1977-04-21 Werkwijze voor het bereiden van een geattenueer- de transmissible gastroenteritis(tge)-virusstam voor toepassing in levende vaccins.

Publications (1)

Publication Number Publication Date
BE866150A true BE866150A (fr) 1978-10-19

Family

ID=19828409

Family Applications (1)

Application Number Title Priority Date Filing Date
BE186927A BE866150A (fr) 1977-04-21 1978-04-19 Procede pour la preparation d'une souche virale de gastro-enterite transmissible attenuee a appliquer aux vaccins vivants

Country Status (14)

Country Link
US (1) US4159319A (fr)
JP (1) JPS53133629A (fr)
AU (1) AU525486B2 (fr)
BE (1) BE866150A (fr)
CA (1) CA1124646A (fr)
DE (1) DE2817299A1 (fr)
ES (1) ES468935A1 (fr)
FR (1) FR2388050A1 (fr)
GB (1) GB1597259A (fr)
IT (1) IT1094413B (fr)
NL (1) NL7704348A (fr)
PL (1) PL109646B1 (fr)
SU (1) SU971108A3 (fr)
YU (1) YU93178A (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601251A1 (fr) * 1986-07-09 1988-01-15 Pensaert Maurice Agent viral non pathogene pour la prevention de la gastroenterite transmissible porcine, son obtention et son utilisation comme vaccin.
EP0679088B1 (fr) * 1992-09-29 2002-07-10 Inhale Therapeutic Systems Liberation dans les poumons de fragments actifs d'hormone parathyroidienne
ATE416755T1 (de) 1994-03-07 2008-12-15 Nektar Therapeutics Verfahren und zusammensetzung für die pulmonale darreichung von insulin
US20030113273A1 (en) * 1996-06-17 2003-06-19 Patton John S. Methods and compositions for pulmonary delivery of insulin
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
WO2010144797A2 (fr) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Vaccins contre la grippe avec immunogénicité accrue et leurs utilisations
DK2384761T3 (da) * 2010-05-07 2013-12-09 Deutsches Krebsforsch Modificeret gnaverparvovirus, som er i stand til formering og spredning i humane gliomer
EP2746790B1 (fr) 2012-12-24 2019-12-04 Uniwersytet Morski w Gdyni Procédé et circuit pour mesurer des résistances thermiques individuelles et mutuelles d'un dispositif magnétique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
US3704203A (en) * 1967-08-24 1972-11-28 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US3585108A (en) * 1969-07-14 1971-06-15 Diamond Lab Inc Transmissible gastroenteritis vaccines and methods of producing the same
US4046875A (en) * 1975-07-14 1977-09-06 Richardson-Merrell Inc. Attenuated TGE virus

Also Published As

Publication number Publication date
CA1124646A (fr) 1982-06-01
FR2388050A1 (fr) 1978-11-17
US4159319A (en) 1979-06-26
IT7822442A0 (it) 1978-04-18
DE2817299A1 (de) 1978-10-26
PL206218A1 (pl) 1979-03-26
NL7704348A (nl) 1978-10-24
PL109646B1 (en) 1980-06-30
FR2388050B1 (fr) 1980-10-31
IT1094413B (it) 1985-08-02
AU3520378A (en) 1979-10-25
GB1597259A (en) 1981-09-03
ES468935A1 (es) 1978-12-01
JPS53133629A (en) 1978-11-21
AU525486B2 (en) 1982-11-11
YU93178A (en) 1983-04-30
SU971108A3 (ru) 1982-10-30

Similar Documents

Publication Publication Date Title
BE866150A (fr) Procede pour la preparation d'une souche virale de gastro-enterite transmissible attenuee a appliquer aux vaccins vivants
RO75478A (fr) PROCEDE POUR LA PREPARATION DES DERIVES D'ACIDE ALPROCEDE POUR LA PREPARATION DES DERIVES DE L'ACIDE ALPHA-PHENO0YPROïIONIQUE PHA-PHENOXYPROPIONIQUE
RO78105A (fr) Procede pour la preparation des 2-chlore-6-nitroanilines
FR2470107B1 (fr) Procede de preparation d'acide acrylique
BE874246A (fr) Procede pour la preparation d'esters de d'acide 3-alkylethiopropionique
RO81037A (fr) Procede de preparation des '-desacetyle-vincaleucoblastin-c3-carboxyhydrazide
RO76935A (fr) Procede pour la preparation des benzophenonhydrazones
FR2317253A1 (fr) Procede d'elaboration de materiaux refractaires mineraux coules
RO82359A (fr) Procede pour la preparation des 4-thiazolidinones
FR2445383B1 (fr) Procede de preparation d'isolateurs du type ceramique-metal resistant aux chocs thermiques
LU79397A1 (fr) Procede pour la preparation d'esters d'acide oxalique
RO79398A (fr) Procede pour la preparation des 1-oxa-dethiacephalosporines
PT68275A (fr) Procede pour la preparation de vaccins contre les maladiesprovoquees par des paramixovirus
RO83446A (fr) Procede pour la preparation des cyclopropylmethoxyanilides
LU80424A1 (fr) Procede de preparation de compositions de degagement des souillures
LU80567A1 (fr) Procede pour la preparation de 3-iodo-et de 3 bromorifamycine s
BE867414A (fr) Procede pour la preparation d'hydroxy-alpha-aminobenzylpenicillines
BE827900A (fr) Procede en vue d'immuniser des gorets allaites contre le virus de la gastro-enterite transmissible
BE875159A (fr) Procede de preparation de colorants azoiques, et produits obtenus
RO77326A (fr) Procede pour la preparation des esters phosphoriques et thionophosphoniques de 5(3)-hydroxypyrazoles
BE875161A (fr) Procede pour preparer des monocaryons par dedicaryotisation de souches dicaryotiques de souches dicaryotiques de basidiomcetes
BE862865A (fr) Procede de preparation d'organopolysiloxanes modifies par des esters d'acide acrylique ou methacrylique, et produits ainsi obtenus
RO79023A (fr) Procede de preparation de l'acide 2-(3-phenoxy-phenyle)propionique
RO81116A (fr) Procede pour la preparation des corticoides
SU621575A1 (ru) Устройство дл укладки бетонной смеси в форму

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: DUPHAR INTERNATIONAL RESEARCH B.V.

Effective date: 19850419